Particle.news
Health ❯ Healthcare ❯ Clinical Trials ❯ Phase III Trials
Investigators say the PFS benefit gives a rationale to test the STRIDE immunotherapy strategy earlier in treatment while overall survival continues to mature under follow-up.
